Thrombophilia secondary prevention: Difference between revisions

	Thrombophilia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thrombophilia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Thrombophilia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Thrombophilia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thrombophilia secondary prevention
CDC on Thrombophilia secondary prevention
Thrombophilia secondary prevention in the news
Blogs on Thrombophilia secondary prevention
Directions to Hospitals Treating Thrombophilia
Risk calculators and risk factors for Thrombophilia secondary prevention

Revision as of 22:50, 30 June 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Asiri Ediriwickrema, M.D., M.H.S. [2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Thrombophilia}}
-{{CMG}} {{AE}}
+{{CMG}} {{asiri}}
 ==Overview==
-Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 ==Secondary Prevention==
+Refer to [[Thrombophilia_medical_therapy|medical therapy for thrombophilias]].
 ==References==